Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Fox

Showing results (91-100 of 182) with videos related to

Pageof 19
Sort By:
Pharmaceutics|June 24, 2022
Pre-Clinical Evaluation of Tenofovir and Tenofovir Alafenamide for HIV-1 Pre-Exposure Prophylaxis in Foreskin TissueLaura Else, Sujan D Penchala, Azure-Dee Pillay, et al.
Journal of the International AIDS Society|November 14, 2014
Enhanced normalisation of CD4/CD8 ratio with early antiretroviral therapy in primary HIV infectionJohn Thornhill, Jamie Inshaw, Soonita Oomeer, et al.
The Journal of Antimicrobial Chemotherapy|May 16, 2021
Pharmacokinetic/pharmacodynamic investigation of raltegravir with or without lamivudine in the context of HIV-1 pre-exposure prophylaxis (PrEP)Carolina Herrera, Julianne Lwanga, Ming Lee, et al.
The Journal of Clinical Investigation|January 26, 2005
HIV-1-specific CD4+ T lymphocyte turnover and activation increase upon viral reboundThomas J Scriba, Hua-Tang Zhang, Helen L Brown, et al.
Journal of Public Health in Africa|October 10, 2025
Understanding sexual violence: Perspectives from an adolescent HIV prevention studyNadia Ahmed, Emily Webb, Richard Muhumuza, et al.
HIV Medicine|March 19, 2026
Missed opportunities to prevent HIV acquisition with pre-exposure prophylaxis: A mixed methods study of people with recently acquired HIV in the United KingdomArgyro Karakosta, Emily Jay Nicholls, Flavien Coukan, et al.
AIDS (London, England)|December 22, 2023
Rapid antiretroviral therapy in primary HIV-1 infection enhances immune recoveryJohn Patrick Thornhill, Julie Fox, Genevieve Elizabeth Martin, et al.
International Journal of STD & AIDS|April 14, 2025
Post-acute sequelae of COVID-19 in people of Black ethnicities living with HIV in the United KingdomZoe Ottaway, Lucy Campbell, Julie Fox, et al.
The Journal of Antimicrobial Chemotherapy|October 31, 2018
Effect of valaciclovir on CD4 count decline in untreated HIV: an international randomized controlled trialDarrell H S Tan, Janet M Raboud, Leah Szadkowski, et al.
Plos One|May 26, 2012
Comparison of sexual behavior and HIV risk between two HIV-1 serodiscordant couple cohorts: the CHAVI 002 studyAdam J Ritchie, Kristin Kuldanek, Zoe Moodie, et al.
Pageof 19

Showing results (91-100 of 182) with videos related to

Sort By:
Pageof 19
Pharmaceutics|June 24, 2022
Pre-Clinical Evaluation of Tenofovir and Tenofovir Alafenamide for HIV-1 Pre-Exposure Prophylaxis in Foreskin TissueLaura Else, Sujan D Penchala, Azure-Dee Pillay, et al.
Journal of the International AIDS Society|November 14, 2014
Enhanced normalisation of CD4/CD8 ratio with early antiretroviral therapy in primary HIV infectionJohn Thornhill, Jamie Inshaw, Soonita Oomeer, et al.
The Journal of Antimicrobial Chemotherapy|May 16, 2021
Pharmacokinetic/pharmacodynamic investigation of raltegravir with or without lamivudine in the context of HIV-1 pre-exposure prophylaxis (PrEP)Carolina Herrera, Julianne Lwanga, Ming Lee, et al.
The Journal of Clinical Investigation|January 26, 2005
HIV-1-specific CD4+ T lymphocyte turnover and activation increase upon viral reboundThomas J Scriba, Hua-Tang Zhang, Helen L Brown, et al.
Journal of Public Health in Africa|October 10, 2025
Understanding sexual violence: Perspectives from an adolescent HIV prevention studyNadia Ahmed, Emily Webb, Richard Muhumuza, et al.
HIV Medicine|March 19, 2026
Missed opportunities to prevent HIV acquisition with pre-exposure prophylaxis: A mixed methods study of people with recently acquired HIV in the United KingdomArgyro Karakosta, Emily Jay Nicholls, Flavien Coukan, et al.
AIDS (London, England)|December 22, 2023
Rapid antiretroviral therapy in primary HIV-1 infection enhances immune recoveryJohn Patrick Thornhill, Julie Fox, Genevieve Elizabeth Martin, et al.
International Journal of STD & AIDS|April 14, 2025
Post-acute sequelae of COVID-19 in people of Black ethnicities living with HIV in the United KingdomZoe Ottaway, Lucy Campbell, Julie Fox, et al.
The Journal of Antimicrobial Chemotherapy|October 31, 2018
Effect of valaciclovir on CD4 count decline in untreated HIV: an international randomized controlled trialDarrell H S Tan, Janet M Raboud, Leah Szadkowski, et al.
Plos One|May 26, 2012
Comparison of sexual behavior and HIV risk between two HIV-1 serodiscordant couple cohorts: the CHAVI 002 studyAdam J Ritchie, Kristin Kuldanek, Zoe Moodie, et al.
Pageof 19